Invitation to teleconference for analysts, investors and media

Presentation of Meda’s First Quarter Results 2016

On Tuesday, May 3rd, 2016 at 8:00 CET, Meda will release its First Quarter Results for 2016. Meda invites all analysts, investors and media to a teleconference to be held on Tuesday,   May 3rd at 10:00 CET!

During the teleconference, CEO Jörg-Thomas Dierks and CFO Henrik Stenqvist will present the 2016 First Quarter report.

The First Quarter report will be available at Meda’s website, Slides from the presentation will be available at the same address. The webcast presentation can be heard at:

To participate in the telephone conference, please call:

UK: +442033645374
SE: +46850556474
US: +18557532230

For further information, please contact

Paula Treutiger, +46 8 630 2082


MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit
Invitation to 2016 First Quarter results teleconference

Meda AB (publ)
, corporate ID: 556427-2812

Pipers väg 2A, Box 906, SE-170 09 Solna, Sweden,, Tel: +46-8-630 19 00. Fax: +46-8-630 19 50


About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.


Documents & Links